Clinical trial
Non-Interventional Study on Pulmonary Arterial Hypertension Patients Treated With Macitentan or Selexipag: Experience From an Italian Cohort (INSPECTIO)
NCT04567602 is registered in ClinicalTrials.gov with Janssen-Cilag S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Interventional Study on Pulmonary Arterial Hypertension Patients Treated With Macitentan or Selexipag: Experience From an Italian Cohort (INSPECTIO)
- Lead sponsor
- Janssen-Cilag S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 6, 2020
- Completion date
- March 5, 2024
- Enrollment
- 372 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.